JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB259222

Human UBE2H knockout HCT116 cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

UBE2H KO cell lysate available now. KO validated by. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon1 and Insertion of the selection cassette in exon1.

View Alternative Names

E2 20K, GID complex subunit 3 UBC8 homolog, GID3, UBC8, UBCH, UBCH 2, UBE2H_HUMAN, Ubiquitin carrier protein H, Ubiquitin conjugating enzyme E2H (UBC8 homolog yeast), Ubiquitin-conjugating enzyme E2 H, Ubiquitin-conjugating enzyme E2-20K, Ubiquitin-conjugating enzyme E2H (homologous to yeast UBC8), Ubiquitin-protein ligase H

2 Images
Sanger Sequencing - Human UBE2H knockout HCT116 cell lysate (AB259222)
  • Sanger seq

Unknown

Sanger Sequencing - Human UBE2H knockout HCT116 cell lysate (AB259222)

Allele-2 : Insertion of the selection cassette in exon1

Sanger Sequencing - Human UBE2H knockout HCT116 cell lysate (AB259222)
  • Sanger seq

Unknown

Sanger Sequencing - Human UBE2H knockout HCT116 cell lysate (AB259222)

Allele-1 : 1 bp deletion in exon1

Key facts

Cell type

HCT116

Species or organism

Human

Tissue

Colon

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon1 and Insertion of the selection cassette in exon1.

Disease

Carcinoma

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab259222-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human wild-type HCT116 cell lysate", "number":"AB259222-CMP02", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human UBE2H knockout HCT116 cell lysate", "number":"AB259222-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
UBE2H
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Ubiquitin-conjugating enzyme E2 H (Ube2H) also known as UBC8 is an enzyme that functions mechanically to facilitate the transfer of ubiquitin to substrate proteins a process essential for regulating protein degradation. Ube2H weighs approximately 20 kDa and shows expression in various tissues especially in the liver and skeletal muscle. It belongs to the E2 ubiquitin-conjugating enzyme family which plays an important role in the ubiquitin-proteasome pathway.
Biological function summary

Ubiquitin-conjugating enzyme E2 H plays a central role in protein homeostasis by tagging proteins for proteasomal degradation. It does not function alone but as part of larger complexes that include E1 activating enzymes and E3 ubiquitin ligases. These complexes work in synchrony to ensure precise ubiquitination of target proteins which helps regulate multiple cellular processes such as cell cycle progression DNA repair and immune response.

Pathways

Ubiquitin-conjugating enzyme E2 H integrates with several critical cellular pathways including the ubiquitin-proteasome pathway and the DNA damage response pathway. In the ubiquitin-proteasome pathway Ube2H works alongside other E2 enzymes like Ube2C to assist in the ubiquitination process. It has a notable connection with proteins like p53 and BRCA1 which are vital in maintaining genomic stability and tumor suppression.

Ubiquitin-conjugating enzyme E2 H has recognized implications in cancer and neurodegenerative diseases. Aberrations in its function can lead to improper protein degradation contributing to the accumulation of defective proteins that can cause cellular dysfunction. In cancer Ube2H is often linked with anomalies in the ubiquitin-proteasome system affecting the degradation of oncogenic proteins. Additionally its interaction with p53 a protein known for its tumor suppressor functions highlights its potential involvement in cancer progression when dysregulated.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 1 US: 1

Adherent/suspension

Adherent

Gender

Male

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com